New generation remedies for cancer treatments are challenging resilient cancer conditions in patients. Previously known as BOS172722, was tested in animals to study the effectiveness of paclitaxel which is kind of Chemotherapy used in treating triple-negative breast cancer, one of deadliest breast cancer known to mankind.
A human trial of this procedure is scheduled to be performed. If it is a success, it can be expanded to treat lung and ovarian cancer.
Reference Link: https://www.newscientist.com/article/2218935-anti-evolution-drug-may-help-treat-resistant-breast-cancers/